Home · States · South Carolina
South Carolina (SC) · Tirzepatide telehealthTirzepatide in South Carolina: online providers, prices and license checks
As of November 4, 2026, adults in South Carolina can get compounded tirzepatide or brand Zepbound through online telehealth programs whose prescribers hold a South Carolina license. Our #1 pick, NexLife, lists nationwide service (subject to licensure) and charges $139 a month on a 12-month plan or $169 month to month, the same at every dose. Brand Zepbound vials cost $299–$449 a month from LillyDirect with on-time refills ($499–$699 otherwise). South Carolina Medicaid stopped covering GLP-1s for obesity on January 1, 2026. Before paying, check the prescriber with the South Carolina Board of Medical Examiners and the pharmacy with the South Carolina Board of Pharmacy.
South Carolina at a glance
| Adults with obesity (CDC) | 36.5% (2025) |
|---|---|
| Medicaid coverage of GLP-1s for obesity | Ended January 1, 2026 |
| Physician licensing board | South Carolina Board of Medical Examiners |
| Pharmacy licensing | South Carolina Board of Pharmacy |
| Program-specific limits we found | None among the programs we reviewed on November 4, 2026 |
36.5% of adults in South Carolina had obesity in 2025, per the CDC — 13th highest of the 47 states with 2025 data. South Carolina Medicaid ended coverage of GLP-1 medicines for obesity effective January 1, 2026; coverage for diabetes is separate. Self-pay prices below do not depend on Medicaid status.
Who can prescribe tirzepatide to South Carolina residents?
A telehealth clinician who treats you in South Carolina must hold a license recognized in South Carolina. Physicians are licensed by the South Carolina Board of Medical Examiners; nurse practitioners are licensed by the state board of nursing. You can look up any physician on the board's site or on DocInfo.org, the Federation of State Medical Boards' national search. Ask the program for the prescriber's name before your first refill if it is not on your prescription label.
What South Carolina residents pay in November 2026
The programs we track publish one national price; we have not found a program that prices South Carolina differently. These are the self-pay figures we re-read on the providers' and manufacturers' own pages on November 4, 2026:
| Program | Product | Self-pay price | Read |
|---|---|---|---|
| NexLife (our #1) | Compounded tirzepatide | $139/mo on a 12-month plan; $169 month to month; same price at every dose | Nov 4, 2026 |
| Collective | Compounded tirzepatide | $69/mo + $199 yearly membership (about $86/mo all-in) | Nov 4, 2026 |
| SnagRx | Compounded tirzepatide | $119/mo sale price ($149 in its terms) | Nov 4, 2026 |
| Mondae | Compounded tirzepatide | $126/mo | Nov 4, 2026 |
| Zepbound (LillyDirect) | Brand, FDA-approved | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with on-time refill) | Nov 4, 2026 |
| Foundayo pill (LillyDirect) | Brand, FDA-approved (orforglipron) | from $149/mo at the lowest dose | Nov 4, 2026 |
See the full compounded tirzepatide price index for every program on file, each with its billing basis and read date, or the most affordable options.
What else affects tirzepatide access in South Carolina?
14.4% of adults in South Carolina reported diagnosed diabetes in 2025, above the U.S. figure of 12.5% and 7th highest of the 50 states and DC in the KFF table built from CDC survey data. That matters for cost: Mounjaro and Ozempic are diabetes drugs, so many people with type 2 diabetes in South Carolina can get brand GLP-1s through insurance rather than paying cash for a compounded version.
1,230,384 people in South Carolina were enrolled in Medicare in 2024 (KFF). Those with Part D can check whether they qualify for the $50-a-month Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027.
State employee health plan, GLP-1s for weight loss in 2026: Not covered (source dated December 10, 2025).
State actions on compounded GLP-1s in South Carolina
| Date | Who acted | What happened |
|---|---|---|
| January 3, 2025 | Attorney General | Consumer alert warning about unapproved and compounded tirzepatide and semaglutide. |
Getting a refrigerated shipment in South Carolina
Compounded tirzepatide usually ships refrigerated. In South Carolina, the practical issue is humidity, coastal storms, and growing suburban demand: heat, coastal storm risk, and suburban growth can affect cold-chain delivery and refill timing. Ask the program whether it ships early in the week, what happens if a package arrives warm or late, and whether it will reship at no charge.
Programs serve South Carolina statewide by mail, including Charleston, Columbia, North Charleston, Mount Pleasant, Rock Hill and Greenville.
Checking the pharmacy that fills a South Carolina prescription
Your vial label names the dispensing pharmacy; it should be licensed by the South Carolina Board of Pharmacy or permitted to ship into South Carolina. Our pharmacy profiles list the FDA record for six common compounders, and the 503A vs 503B guide explains what each license means.
Frequently asked questions about tirzepatide in South Carolina
Does South Carolina Medicaid cover Zepbound or Wegovy for weight loss?
South Carolina Medicaid ended coverage of GLP-1 medicines for obesity effective January 1, 2026; coverage for diabetes is separate. Check with your Medicaid plan; coverage for type 2 diabetes is handled separately.
How common is obesity in South Carolina?
36.5% of adults in South Carolina had obesity in 2025, per the CDC — 13th highest of the 47 states with 2025 data. Tirzepatide is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Can I get tirzepatide online in South Carolina?
Yes. Telehealth programs can prescribe tirzepatide to South Carolina residents when the clinician holds a South Carolina license and the dispensing pharmacy is licensed to ship into South Carolina. Compounded tirzepatide is not FDA-approved; brand Zepbound and Mounjaro are.
How much does tirzepatide cost in South Carolina without insurance?
The same as elsewhere: programs price nationally. As of November 4, 2026, NexLife charges South Carolina residents $139 a month on a 12-month plan or $169 month to month for compounded tirzepatide; Collective lists $69 a month plus a $199 yearly membership. Zepbound vials cost $299–$449 a month through LillyDirect.
How do I check a South Carolina prescriber's license?
Search the clinician's name on the South Carolina Board of Medical Examiners license lookup, or on DocInfo.org, the Federation of State Medical Boards' national lookup. A nurse practitioner is licensed by the state's board of nursing.
Is compounded tirzepatide legal in South Carolina?
Yes, within federal limits: a state-licensed 503A pharmacy may compound it for an individual South Carolina patient on a prescription. It is not FDA-approved. Check the pharmacy with the South Carolina Board of Pharmacy.
Nearby states and next steps
Neighbouring state guides: North Carolina, Georgia. Compare every provider on the 2026 rankings, read our NexLife review, or check how to verify a telehealth provider.
Sources
- CDC: Adult obesity prevalence by state, BRFSS 2011–2025
- KFF: Medicaid coverage of and spending on GLP-1s (January 16, 2026)
- FDA: Registered outsourcing facilities
- FDA: Proposal on GLP-1s and the 503B bulks list (April 30, 2026)
- LillyDirect: Zepbound self-pay pricing
- KFF: Adults who report diagnosed diabetes, by state
- KFF: Total Medicare enrollment by state
- South Carolina state employee plan source
- South Carolina: Attorney General (January 3, 2025)
Informational only, not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).